(Bloomberg) -- Traders are almost 100% certain that Amgen Inc. will complete its $28 billion takeover of Horizon Therapeutics Plc after the Federal Trade Commission paused its in-house case to block the deal.Most Read from BloombergChina’s Worsening Economic Slowdown Is Rippling Across the Globe3M Agrees to Pay More Than $5.5 Billion Over Combat EarplugsTraders Have S&P 500 Comebacks Fading at Historic PaceAuto Union Boss Wants 46% Raise, 32-Hour Work Week in ‘War’ Against Detroit CarmakersTrump